Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not require syringes. It comes as a pre-filled KwikPen — each pen contains four weekly doses and has its own built-in needle system, so you never need to draw up a syringe yourself. The pen is ready to use straight from the fridge. That said, questions about syringes, needles and injection technique are ones our prescribers hear regularly, so it is worth understanding exactly what equipment Mounjaro actually uses, what you might genuinely need to buy separately, and where the confusion tends to come from. As a Prescription-Only Medicine, Mounjaro requires a clinical assessment from a registered prescriber before treatment can begin — the pen format and any associated equipment are part of what your prescriber will explain when they review your consultation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is a completely understandable thing to search. If you have any experience with insulin or older injectable medicines, syringes and vials are what you'd expect. Mounjaro works differently. Eli Lilly designed the KwikPen as a self-contained device, the medication is already inside, at the correct concentration, and you attach a fine pen needle to the tip before each weekly injection. There is no mixing, no drawing up and no measuring. The question of which syringe to use for Mounjaro has a short answer: none, because the pen replaces the syringe entirely.
Where the confusion often comes from is people switching from insulin therapy, or from compounded or counterfeit versions of tirzepatide sold in vials online. Vial-based tirzepatide does require syringes, but those products are not licensed in the UK. The only legitimate UK form of tirzepatide for weight management is the Mounjaro KwikPen, supplied through a licensed pharmacy, as the NHS medicines page for tirzepatide confirms. If a seller is offering tirzepatide in a vial with syringes, that is a significant red flag.
The KwikPen itself does not come with needles included in all supply arrangements. A fresh needle should be attached for each injection and removed immediately afterwards, reusing needles blunts the tip, increases discomfort and raises the risk of infection or blocked delivery. Standard pen needles (4 mm or 5 mm, 32G is commonly preferred for comfort) are the right fit; pen needle sizing for Mounjaro is covered separately if you want the detail on gauge and length.
You will also need a sharps disposal container. Used needles must go into an approved sharps bin, not the household bin, your local pharmacy or council will arrange collection. Keep the pen itself in the fridge between doses (2–8°C); a lot of people find the door shelf works well, sitting alongside anything else that needs to stay cold. For exact storage guidance (including how long the pen can be kept at room temperature before use) the Patient Information Leaflet that comes with your pen is the definitive source. Always check it rather than relying on a general article.
For complete detail on whether an insulin syringe could work with Mounjaro, the short answer is still no, but that page covers the question fully if it has come up for you.
Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above where at least one weight-related health condition is present, such as high blood pressure, type 2 diabetes or high cholesterol. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. BMI alone does not guarantee approval; a prescriber weighs the full clinical picture. The age eligibility for Mounjaro is adults only, the medicine is not licensed for under-18s.
At nume (sorry, at a clinician-led service like ours) every consultation is read by a GPhC-registered Independent Prescriber, not software. If approved, treatment is dispatched the same day for free next-working-day delivery, in plain unbranded packaging. The prescriber will confirm the pen format you are being supplied and walk through injection technique as part of the aftercare process. You can also find a broader overview of how Mounjaro works as a weight-loss treatment if you are still at the research stage.
NICE's appraisal of tirzepatide (TA1026, published December 2024) sets out the clinical basis for its use in weight management. It is a useful read if you want the full evidence picture before making any decisions. If you are comparing treatment options more broadly, our guide to how Nevolat compares with Mounjaro is worth reading alongside the weight-loss treatments overview of what is currently licensed in the UK.
Ready to find out whether you are clinically suitable? Start your free consultation and a prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.